Raymond James & Associates Enovis Corp Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Enovis Corp stock. As of the latest transaction made, Raymond James & Associates holds 56,692 shares of ENOV stock, worth $2.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,692
Previous 4,818
1076.67%
Holding current value
$2.65 Million
Previous $217,000
1024.42%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ENOV
# of Institutions
310Shares Held
60.3MCall Options Held
1.68MPut Options Held
693K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.63MShares$310 Million0.17% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$253 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$253 Million0.0% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH3MShares$140 Million0.54% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.99MShares$139 Million0.03% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.53B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...